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Background
Diabetes mellitus (DM) is a heterogeneous group of
metabolic disorders which affects over 10% of the world
population. The diabetes-induced oxidized low-density
lipoprotein (ox-LDL) can affect several components of
the atherogenic process [1]. Nanodosage forms can pro-
vide advantages for herbal drugs, including increase of
therapeutic index, improvement of stability and con-
trolled delivery.
Objectives
To evaluate the effect of NPASc and the major constitu-
ents of the extract (gallic acid, GA; chlorogenic acid,
CA; rutin, R) on the levels of lipoperoxidation of
ox-LDL particles by AAPH, in vitro.
Materials and methods
LDL was isolated from human serum (n=6) [2]. LDL iso-
lated samples were incubated with/without NPASc, GA,
CA and R (0.1; 0.25; 0.5 and 1 mg/mL) at 37°C for 30 min.
At the end of incubation, the samples were oxidized in the
presence of 20 µM AAPH, for 4 h at 37°C. The oxidation
was estimated by measuring the thiobarbituric acid reac-
tive substances (TBARS, nmol MDA/mg of protein) [3].
N° of the Ethic Committee (0049.0.243.000-08).
Results
Our results demonstrate that NPASc and the com-
pounds protected LDL particles from the oxidation by
AAPH, demonstrating that the known antioxidant activ-
ity of S. cumini was maintained. GA and CA showed a
significant antioxidant activity, although less than that
observed with NPASc; R had a lower effect when com-
pared to other groups. This result confirms the possible
antiatherogenic potential of the extract.
Conclusion
NPASc could act to lower the ox-LDL presence in the
circulation, reducing the number of proatherogenic
potentials thus avoiding the formation of atherosclerotic
lesions.
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Figure 1 NPASc, GA, CA and R activities against ox-LDL in the
AAPH assay. Data are mean±S.E.M (n=6). Differences among
compounds within the same concentration: *p<0.05 compared to
all; **p<0.05 compared to NPASc
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